Boston Scientific wins CE mark for mapping system; Globus launches spinal spacer;

Medical Device News

@FierceMedDev: Boston Scientific: Watchman beats warfarin in follow-up. Article | Follow @FierceMedDev

@MarkHFierce: Nanostim's leadless pacer has had some success in early human trials. Future buyer St. Jude Medical must be pleased. Story | Follow @MarkHFierce

 @DamianFierce: St. Jude: Independent analysis says Durata leads are safe, reliable. Report | Follow @DamianFierce

> Boston Scientific ($BSX) won a CE mark for Rhythmia, a 3-D mapping system used in electrophysiology procedures. Story

> Globus Medical ($GMED) has launched its Fortify I corpectomy spacer for spinal surgery. News

> Rosetta Genomics ($ROSG) has settled its spat with Sanra Laboratories, receiving a $625,000 payment. More

> Bacterin ($BONE) posted $8.6 million in first-quarter revenue, a 6% jump, and the company narrowed its losses by 3% to $1.2 million. Results

> Life Care Medical Devices has expanded into Europe, opening a Dublin outpost to base its continental operations. Item

> Critical Diagnostics is touting a new study establishing the ST2 biomarker, used in the company's Presage ST2 Assay, as the most potent predictor of heart failure rehospitalization. Release

Biotech News

@FierceBiotech: Novartis' Ilaris approved by FDA to treat active systemic juvenile idiopathic arthritis. Release | Follow @FierceBiotech

@JohnCFierce: Looks like Takeda management maybe in for more changes.The numbers are awful. Report | Follow @JohnCFierce

@RyanMFierce: My story on how industry legend Henri Termeer rediscovers the 'Genzyme feel' in world of biotech startups. Article | Follow @RyanMFierce

> Pain Therapeutics, Durect shares nosedive on haziness for Pfizer's Remoxy. Report

> Eli Lilly jettisons cancer contender after another Phase III failure. Story

> Biotech VC firm Frazier Healthcare closes in on $300M fund. More

> Deborah Dunsire exits as Takeda cuts CEO role in Millennium shakeup. News

Pharma News

@FiercePharma: WSJ: J&J's multibillion-$$ Risperdal settlement snags on breast side effects. $JNJ worried a/b civil suits. Article | Follow @FiercePharma

@EricPFierce: Pharma M&A way up in Q1 2013 compared to a year ago. Value up more than 500%. Feature | Follow @EricPFierce

> Motherhood at center of Merck gender bias suit. Article

> Amgen forges Chinese JV for Vectibix. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.